CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, L. L.
Right arrow Articles by Wilkens, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, L. L.
Right arrow Articles by Wilkens, L. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 495-500, June 1999
© 1999 American Association for Cancer Research

Genetic and Dietary Predictors of CYP2E1 Activity: A Phenotyping Study in Hawaii Japanese Using Chlorzoxazone1

Loïc Le Marchand2, Grant R. Wilkinson and Lynne R. Wilkens

Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813 [L. L. M., L. R. W.], and Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232 [G. R. W.]

Cytochrome P4502E1 (CYP2E1) is considered to play an important role in the metabolic activation of procarcinogens such as N-nitrosoamines and low molecular weight organic compounds. An RsaI polymorphism is present in the 5'-flanking region of the CYP2E1 gene, which could possibly affect its transcription. However, the relationship between genotype and the phenotypic catalytic activity of the enzyme has not been defined. Also, the effects in humans of specific dietary factors, other than ethanol, which have been shown in animal and in vitro studies to modulate CYP2E1 activity, are unknown. Accordingly, the CYP2E1-mediated metabolism of chlorzoxazone to its 6-hydroxy metabolite was investigated in 50 healthy Japanese of both sexes in Hawaii. The oral clearance of the in vivo probe, the trait measure of CYP2E1 activity, was smaller than that reported in European-Americans. Significantly, after adjustment for age and sex, the oral clearance of chlorzoxazone decreased with the number of variant c2 alleles, and its mean in the c2/c2 genotype (147 ml/min) was statistically lower (P <= 0.05) than that for either the homozygous wild-type (238 ml/min) or the heterozygote (201 ml/min) genotypes. Stepwise multiple regression analysis indicated that body weight was a major contributor to the interindividual variability in the oral clearance of chlorzoxazone, accounting for 43% of the variance. Consumption of lettuce, broccoli, and black tea explained additional components of the variability (7, 5, and 6%, respectively), as did medication use (3%), age (4%), and CYP2E1 genotype (5%). Overall, 73% of the variance could be accounted for by these variables. Body weight, lettuce, and use of medications were associated with increased CYP2E1 activity, and the other covariates were associated with reduced enzyme function. Because of the role that CYP2E1 plays in procarcinogen activation, especially of N-nitrosamines involved in lung cancer, the identified factors may account in part for observed differences in individual susceptibility to disease and may also have implications for cancer prevention.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
D.-J. Kim, I.-G. Choi, B. L. Park, B.-C. Lee, B.-J. Ham, S. Yoon, J. S. Bae, H. S. Cheong, and H. D. Shin
Major genetic components underlying alcoholism in Korean population
Hum. Mol. Genet., March 15, 2008; 17(6): 854 - 858.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Kury, B. Buecher, S. Robiou-du-Pont, C. Scoul, V. Sebille, H. Colman, C. Le Houerou, T. Le Neel, J. Bourdon, R. Faroux, et al.
Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1460 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. De Roos, L. S. Gold, S. Wang, P. Hartge, J. R. Cerhan, W. Cozen, M. Yeager, S. Chanock, N. Rothman, and R. K. Severson
Metabolic Gene Variants and Risk of Non-Hodgkin's Lymphoma.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1647 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Matsuo, K. Wakai, K. Hirose, H. Ito, T. Saito, and K. Tajima
Alcohol Dehydrogenase 2 His47Arg Polymorphism Influences Drinking Habit Independently of Aldehyde Dehydrogenase 2 Glu487Lys Polymorphism: Analysis of 2,299 Japanese Subjects.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1009 - 1013.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Matsuo, K. Wakai, K. Hirose, H. Ito, T. Saito, T. Suzuki, T. Kato, T. Hirai, Y. Kanemitsu, H. Hamajima, et al.
A gene-gene interaction between ALDH2 Glu487Lys and ADH2 His47Arg polymorphisms regarding the risk of colorectal cancer in Japan
Carcinogenesis, May 1, 2006; 27(5): 1018 - 1023.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
Molecular Targets for Bioactive Food Components
J. Nutr., September 1, 2004; 134(9): 2492S - 2498S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. De Roos, N. Rothman, P. D. Inskip, M. S. Linet, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, G. S. Pittman, and D. A. Bell
Genetic Polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the Risk of Adult Brain Tumors
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 14 - 22.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Le Marchand, T. Donlon, A. Seifried, and L. R. Wilkens
Red Meat Intake, CYP2E1 Genetic Polymorphisms, and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1019 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Gao, T. Takezaki, J. Wu, Z. Li, J. Wang, J. Ding, Y. Liu, X. Hu, T. Xu, K. Tajima, et al.
Interaction between Cytochrome P-450 2E1 Polymorphisms and Environmental Factors with Risk of Esophageal and Stomach Cancers in Chinese
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 29 - 34.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
G. D. Stoner and A. Gupta
Etiology and chemoprevention of esophageal squamous cell carcinoma
Carcinogenesis, November 1, 2001; 22(11): 1737 - 1746.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
G D Loizou and J Cocker
The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone
Human and Experimental Toxicology, July 1, 2001; 20(7): 321 - 327.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. N. Nishimoto, T. Hanaoka, H. Sugimura, K. Nagura, M. Ihara, X.-J. Li, T. Arai, G. S. Hamada, L. P. Kowalski, and S. Tsugane
Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians
Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 675 - 680.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Tan, N. Song, G.-Q. Wang, Q. Liu, H.-J. Tang, F. F. Kadlubar, and D.-X. Lin
Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione S-Transferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 551 - 556.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.